2-acetylaminofluorene has been researched along with Angiogenesis, Pathologic in 1 studies
2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikebe, T | 1 |
| Yamamoto, T | 1 |
| Kubo, S | 1 |
| Hirohashi, K | 1 |
| Kinoshita, H | 1 |
| Kaneda, K | 1 |
| Sakurai, M | 1 |
1 other study available for 2-acetylaminofluorene and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Suppressive effect of the angiogenesis inhibitor TNP-470 on the development of carcinogen-induced hepatic nodules in rats.
Topics: 2-Acetylaminofluorene; Animals; Antibiotics, Antineoplastic; Carcinogens; Cyclohexanes; Hyperplasia; | 1998 |